Anogenital cancers testing in Castro dei Volsci

Find health labs to test for Anogenital cancers in Castro dei Volsci and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Smear by Laboratorio Lifebrain

Via Antonino Carnevale, Madonna del Piano, Castro dei Volsci FR, Italia 03020 Frosinone (FR)

Unverified

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Test by Farmacia Poce

Via Santa Filomena, 48, 03025 Monte San Giovanni Campano FR, Italia

10.6 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Morolense, 20 03019 Supino (Frosinone )

11.7 km

Unverified

See Details

Pap Smear by Synlab

Via della Concordia, 12, 00030 Montelanico RM, Italia

21.3 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Fontana Bracchi, 63 00034 Colleferro (Roma)

25.8 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Corso Garibaldi, 31 00034 Colleferro (RM)

25.8 km

Unverified

See Details

Pap Smear by Centro Medico di Patologia Clinica Redi

Via Guglielmo Oberdan, 42, 04100 Latina LT, Italia

26.2 km

Unverified

See Details

Pap Test by Centro Analisi Piave

Via Giorgio La Pira, 8, 04100 Latina LT, Italia

26.2 km

Unverified

A Pap Smear costs €48.00

See Details

Pap Smear by Laboratorio Lifebrain

Via Rovereto, 21 67032 Pescasseroli (AQ)

28.6 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Giuseppe di Vittorio, 5 00031 Artena (Roma)

29.9 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Molino San Giovanni snc 00038 Valmontone (RM)

31.3 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.